A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients.
Biyun WangYannan ZhaoYi LiYingying XuYun ChenQiuyu JiangDingjin YaoLi ZhangXichun HuChaowei FuSi ZhangShe ChenPublished in: Molecular cancer (2022)